Related Experiment Video
Updated: Aug 4, 2026
Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
Published on: January 16, 2013
Amide Penicillin Wy-12,556: therapeutic activity in animals subjected to repeated bacterial infection
Abstract:
Amide penicillin Wy-12,556 and DBED penicillin were studied for their antibacterial effect in CD-1 mice repeatedly infected with Streptococcus pyogenes C203 and/or Staphylococcus aureus Smith. Animals infected with S. aureus Smith failed to show a difference between the therapeutic activity of DBED penicillin and Wy-12,556. Wy-12,556 was significantly more effective than DBED penicillin in protecting the animals challenged repeatedly with S. pyogenes C203. Wy-12,556 provoked a positive transient chemotactic response in uninfected mice. 24 h after intraperitoneal challenge the exudate showed a high neutrophilic count.
Insights
Amide penicillin Wy-12,556 demonstrated superior efficacy over DBED penicillin against Streptococcus pyogenes infections in mice. Both penicillins showed similar effects on Staphylococcus aureus infections.
Area of Science:
- Microbiology
- Pharmacology
- Immunology
Background:
- Streptococcus pyogenes and Staphylococcus aureus are significant bacterial pathogens.
- Penicillin derivatives are crucial in treating bacterial infections.
- Understanding the comparative efficacy of different penicillin formulations is vital for clinical application.
Purpose of the Study:
- To compare the antibacterial effects of amide penicillin Wy-12,556 and DBED penicillin.
- To evaluate the efficacy of these penicillins against Streptococcus pyogenes and Staphylococcus aureus infections in a murine model.
- To investigate the immunomodulatory effects of Wy-12,556.
Main Methods:
- CD-1 mice were repeatedly infected with Streptococcus pyogenes C203 and/or Staphylococcus aureus Smith.
- Therapeutic activity of Wy-12,556 and DBED penicillin was assessed.
- Chemotactic response and neutrophilic counts in peritoneal exudates were analyzed.
Main Results:
- Wy-12,556 was significantly more effective than DBED penicillin against Streptococcus pyogenes.
- No significant difference in therapeutic activity was observed between Wy-12,556 and DBED penicillin against Staphylococcus aureus.
- Wy-12,556 induced a transient chemotactic response with elevated neutrophilic counts in uninfected mice.
Conclusions:
- Amide penicillin Wy-12,556 offers enhanced therapeutic benefits over DBED penicillin for Streptococcus pyogenes infections.
- The differential efficacy suggests pathogen-specific activity profiles for these penicillin formulations.
- Wy-12,556 exhibits immunomodulatory properties, potentially contributing to its therapeutic effect.
